1159186-57-8 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule of the compound.
2. Halogenated benzene derivative
Explanation
It is a compound derived from benzene by substituting one or more hydrogen atoms with halogen atoms (bromine, chlorine, and fluorine in this case).
3. Contains bromine, chlorine, and fluorine atoms
Explanation
These are the halogen atoms present in the compound, which contribute to its reactivity and properties.
4. Building block in synthesis
Explanation
It is commonly used as a starting material for the synthesis of pharmaceuticals, agrochemicals, and other organic compounds.
5. Colorless liquid
Explanation
The compound appears as a colorless liquid at room temperature.
6. Strong, pungent odor
Explanation
The compound has a noticeable and intense smell, which can be detected easily.
7. Highly reactive
Explanation
Due to the presence of multiple halogen atoms, the compound is more reactive than a typical benzene derivative.
8. Safety measures required
Explanation
When handling this compound in a laboratory setting, it is crucial to follow proper safety protocols to minimize the risk of accidents or exposure to harmful effects.
9. Proper handling and storage
Explanation
The compound should be stored in a well-ventilated area, away from heat and ignition sources, and handled with appropriate personal protective equipment (PPE) to ensure the safety of the individuals working with it.
Check Digit Verification of cas no
The CAS Registry Mumber 1159186-57-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,9,1,8 and 6 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1159186-57:
(9*1)+(8*1)+(7*5)+(6*9)+(5*1)+(4*8)+(3*6)+(2*5)+(1*7)=178
178 % 10 = 8
So 1159186-57-8 is a valid CAS Registry Number.
1159186-57-8Relevant articles and documents
PYRAZOLE DERIVATIVES AS 5-LO INHIBITORS
-
Page/Page column 92, (2009/07/03)
The invention relates to compounds of formula (I) processes for their preparation, their use as 5-lipoxygenase inhibitors and pharmaceutical compositions containing the same.
